ATE49965T1 - Verwendung von 2-beta-d-ribofuranosylthiazol-4carboxamiden zur herstellung von medikamenten zur behandlung von krebsartigen tumoren.
- Google Patents
Verwendung von 2-beta-d-ribofuranosylthiazol-4carboxamiden zur herstellung von medikamenten zur behandlung von krebsartigen tumoren.
Info
Publication number
ATE49965T1
ATE49965T1AT81305874TAT81305874TATE49965T1AT E49965 T1ATE49965 T1AT E49965T1AT 81305874 TAT81305874 TAT 81305874TAT 81305874 TAT81305874 TAT 81305874TAT E49965 T1ATE49965 T1AT E49965T1
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vira Tek IncfiledCriticalVira Tek Inc
Priority claimed from EP81305874Aexternal-prioritypatent/EP0054432B1/de
Application grantedgrantedCritical
Publication of ATE49965T1publicationCriticalpatent/ATE49965T1/de
AT81305874T1980-12-151981-12-14Verwendung von 2-beta-d-ribofuranosylthiazol-4carboxamiden zur herstellung von medikamenten zur behandlung von krebsartigen tumoren.
ATE49965T1
(de)